Plasma Lipocalin-2 and Adiponectin are Affected by Obesity Rather Than Type 2 Diabetes Mellitus per se

References

• Flo TH , Smith KD , Sato S , et al. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature . 2004;432:917–921. doi:10.1038/nature03104 15531878
   PubMed Web of Science ®Google Scholar
• Devireddy LR , Gazin C , Zhu X , Green MR . A cell surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake. Cell . 2005;123:1293–1305. doi:10.1016/j.cell.2005.10.027 16377569
   PubMed Web of Science ®Google Scholar
• Yan QW , Yang Q , Mody N , et al. The adipokine lipocalin-2 is regulated by obesity and promotes insulin resistance. Diabetes . 2007;56:2533–2540. doi:10.2337/db07-0007 17639021
   PubMed Web of Science ®Google Scholar
• Catalan V , Gomez-Ambrosi J , Rodriguez A , et al. Increased adipose tissue expression of lipocalin-2 in obesity is related to inflammation and matrix metalloproteinase-2 and metalloproteinase-9 activities in humans. J Mol Med . 2009;87:803–813. doi:10.1007/s00109-009-0486-8 19466389
   PubMed Web of Science ®Google Scholar
• Xu MJ , Feng D , Wu H , et al. Liver is the major source of elevated serum lipocalin-2 levels after bacterial infection or partial hepatectomy: a critical role for IL-6/STAT3. Hepatology . 2015;61:692–702. doi:10.1002/hep.27447 25234944
   PubMed Web of Science ®Google Scholar
• Borkham-Kamphorst E , van de Leur E , Zimmermann HW , et al. Protective effects of lipocalin-2 (LCN2) in acute liver injury suggest a novel function in liver homeostasis. Biochim Biophys Acta . 2013;1832:660–673. doi:10.1016/j.bbadis.2013.01.014 23376114
   PubMed Web of Science ®Google Scholar
• Devarajan P . Neutrophil gelatinase-associated lipocalin: an emerging troponin for kidney injury. Nephrol Dial Transplant . 2008;23:3737–3743. doi:10.1093/ndt/gfn531 18809975
   PubMed Web of Science ®Google Scholar
• Nickolas TL , Forster CS , Sise ME , et al. NGAL (Lcn2) monomer is associated with tubulointerstitial damage in chronic kidney disease. Kidney Int . 2012;82:718–722. doi:10.1038/ki.2012.195 22695331
   PubMed Web of Science ®Google Scholar
• Castillo-Rodriguez E , Fernandez-Prado R , Martin-Cleary C , et al. Kidney injury marker 1 and neutrophil gelatinase-associated lipocalin in chronic kidney disease. Nephron . 2017;136(4):263–267. doi:10.1159/000447649 27771693
   PubMed Web of Science ®Google Scholar
• Costa D , Lazzarini E , Canciani B , et al. Altered bone development and turnover in transgenic mice over-expressing lipocalin-2 in bone. J Cell Physiol . 2013;228(11):2210–2221. doi:10.1002/jcp.24391 23606520
   PubMed Web of Science ®Google Scholar
• Mosialou I , Shikhel S , Liu JM , et al. MC4R-dependent suppression of appetite by bone-derived lipocalin-2. Nature . 2017;543:385–390. doi:10.1038/nature21697 28273060
   PubMed Web of Science ®Google Scholar
• Law IK , Xu A , Lam KS , et al. Lipocalin-2 deficiency attenuates insulin resistance associated with aging and obesity. Diabetes . 2010;59:872–882. doi:10.2337/db09-1541 20068130
   PubMed Web of Science ®Google Scholar
• Oberoi R , Bogalle EP , Matthes LA , et al. Lipocalin (LCN) 2 mediates pro-atherosclerotic processes and is elevated in patients with coronary artery disease. PLoS One . 2015;10:e0137924. doi:10.1371/journal.pone.0137924 26367277
   PubMed Web of Science ®Google Scholar
• Liu Z , Petersen R , Devireddy L . Impaired neutrophil function in 24p3 null mice contributes to enhanced susceptibility to bacterial infections. J Immunol . 2013;190:4692–4706. doi:10.4049/jimmunol.1202411 23543755
   PubMed Web of Science ®Google Scholar
• Venge P , Douhan-Håkansson L , Garwicz D , Peterson C , Xu S , Pauksen K . Human neutrophil lipocalin as a superior diagnostic means to distinguish between acute bacterial and viral infections. Clin Vaccine Immunol . 2015;22:1025–1032. doi:10.1128/CVI.00347-15 26135974
   PubMed Web of Science ®Google Scholar
• Gomez-Chou SB , Swidnicka-Siergiejko AK , Badi N , et al. Lipocalin-2 promotes pancreatic ductal adenocarcinoma by regulating inflammation in the tumor microenvironment. Cancer Res . 2017;77(10):2647–2660. doi:10.1158/0008-5472.CAN-16-1986 28249896
   PubMed Web of Science ®Google Scholar
• Rucci N , Capulli M , Piperni SG , et al. Lipocalin-2: a new mechanoresponding gene regulating bone homeostasis. J Bone Miner Res . 2015;30(2):357–368. doi:10.1002/jbmr.2341 25112732
   PubMed Web of Science ®Google Scholar
• Eilenberg W , Stojkovic S , Piechota-Polanczyk A , et al. Neutrophil gelatinase-associated lipocalin (NGAL) is associated with symptomatic carotid atherosclerosis and drives pro-inflammatory state in vitro. Eur J Vasc Endovasc Surg . 2016;51(5):623–631. doi:10.1016/j.ejvs.2016.01.009 26947538
   PubMed Web of Science ®Google Scholar
• Ni J , Ma X , Zhou M , et al. Serum lipocalin-2 levels positively correlate with coronary artery disease and metabolic syndrome. Cardiovasc Diabetol . 2013;12:176. doi:10.1186/1475-2840-12-176 24359145
   PubMed Web of Science ®Google Scholar
• Wu G , Li H , Fang Q , et al. Elevated circulating lipocalin-2 levels independently predict incident cardiovascular events in men in a population-based cohort. Arterioscler Thromb Vasc Biol . 2014;34:2457–2464. doi:10.1161/ATVBAHA.114.303718 25189569
   PubMed Web of Science ®Google Scholar
• Wang Y , Lam KS , Kraegen EW , et al. Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans. Clin Chem . 2007;53:34–41. doi:10.1373/clinchem.2006.075614 17040956
   PubMed Web of Science ®Google Scholar
• Lee M-W , Lee M , Oh K-J . Adipose tissue-derived signatures for obesity and type 2 diabetes: adipokines, batokines and microRNAs. J Clin Med . 2019;8:854. doi:10.3390/jcm8060854
   PubMed Web of Science ®Google Scholar
• Kocot J , Dziemidok P , Kiełczykowska M , Hordyjewska A , Szcześniak G , Musik I . Adipokine profile in patients with type 2 diabetes depends on degree of obesity. Med Sci Monit . 2017;23:4995–5004. doi:10.12659/MSM.904318 29049270
   PubMed Web of Science ®Google Scholar
• Adiyaman SC , Ozer M , Saydam BO , Akinci B . The role of adiponectin in maintaining metabolic homeostasis. Curr Diabetes Rev . 2020;16(2):95–103. doi:10.2174/1573399815666190702155733 31267874
   PubMed Web of Science ®Google Scholar
• Yanai H , Yoshida H . Beneficial effects of adiponectin on glucose and lipid metabolism and atherosclerotic progression: mechanisms and perspectives. Int J Med Sci . 2019;20:1190.
   Google Scholar
• Ohashi K , Ouchi N , Matsuzawa Y . Anti-inflammatory and anti-atherogenic properties of adiponectin. Biochimie . 2012;94:2137–2142. doi:10.1016/j.biochi.2012.06.008 22713764
   PubMed Web of Science ®Google Scholar
• Yamamoto S , Matsushita Y , Nakagawa T , Hayashi T , Noda M , Mizoue T . Circulating adiponectin levels and risk of type 2 diabetes in the Japanese. Nutr Diabetes . 2014;4:E130. doi:10.1038/nutd.2014.27 25133442
   PubMed Web of Science ®Google Scholar
• Neville CE , Patterson CC , Linden GJ , et al. The relationship between adipokines and the onset of type 2 diabetes in middle-aged men: the PRIME study. Diabetes Res Clin Pract . 2016;120:24–30. doi:10.1016/j.diabres.2016.07.010 27500548
   PubMed Web of Science ®Google Scholar
• Bahceci M , Gokalp D , Bahceci S , Tuzcu A , Atmaca S , Arikan S . The correlation between adiposity and adiponectin, tumor necrosis factor alpha, interleukin-6 and high-sensitivity C-reactive protein levels. Is adipocyte size associated with inflammation in adults? J Endocrinol Invest . 2007;30:210–214. doi:10.1007/BF03347427 17505154
   PubMed Web of Science ®Google Scholar
• Al-Hamodi Z , AL-Habori M , Al-Meeri A , Saif-Ali R . Association of adipokines, leptin/adiponectin ratio and C-reactive protein with obesity and type 2 diabetes mellitus. Diabetol Metab Syndr . 2014;6:99. doi:10.1186/1758-5996-6-99 25276234
   PubMed Web of Science ®Google Scholar
• Huang Y , Yang Z , Ye Z , et al. Lipocalin-2, glucose metabolism and chronic low-grade systemic inflammation in Chinese people. Cardiovasc Diabetol . 2012;11:11. doi:10.1186/1475-2840-11-11 22292925
   PubMed Web of Science ®Google Scholar
• De la Chesnaye E , Manuel-Apolinar L , Zarate A , et al. Lipocalin-2 plasmatic levels are reduced in patients with long-term type 2 diabetes mellitus. Int J Clin Exp Med . 2015;8(2):2853–2859.25932245
   PubMed Web of Science ®Google Scholar
• Rashad NM , El-Shal AS , Etewa RL , Wadea FM . Lipocalin-2 expression and serum levels as early predictors of type 2 diabetes mellitus in obese women. IUBMB Life . 2017;69:88–97. doi:10.1002/iub.1594 28116808
   PubMed Web of Science ®Google Scholar
• Putz DM , Goldner WS , Bar RS , Haynes WG , Sivitz WI . Adiponectin and C-reactive protein in obesity, type 2 diabetes, and monodrug therapy. Metabolism . 2004;53(11):1454–1461. doi:10.1016/j.metabol.2004.06.013 15536601
   PubMed Web of Science ®Google Scholar
• Yuan G , Zhou L , Tang J , et al. Serum CRP levels are equally elevated in newly diagnosed type 2 diabetes and impaired glucose tolerance and related to adiponectin levels and insulin sensitivity. Diabetes Res Clin Pract . 2006;72(3):244–250. doi:10.1016/j.diabres.2005.10.025 16377022
   PubMed Web of Science ®Google Scholar
• Ma L , Xu Y , Zhang Y , Ji T , Li Y . Lower levels of circulating adiponectin in elderly patients with metabolic inflammatory syndrome: a cross-sectional study. Diabetes Metab Syndr Obes . 2020;13:591–596. doi:10.2147/DMSO.S242397 32184638
   PubMed Web of Science ®Google Scholar
• Auguet T , Quintero Y , Terra X , et al. Upregulation of lipocalin-2 in adipose tissues of severely obese women: positive relationship with proinflammatory cytokines. Obesity . 2011;19:2295–2300. doi:10.1038/oby.2011.61 21455126
   PubMed Web of Science ®Google Scholar
• Wang W , Ye S , Qian L , et al. Elevated serum lipocalin-2 levels are associated with indexes of both glucose and bone metabolism in type 2 diabetes mellitus. Endokrynol Pol . 2018;69(3):276–282. doi:10.5603/EP.a2018.0030 29952418
   PubMed Web of Science ®Google Scholar
• Alkharfy KM , Al-Daghri NM , Vanhoutte PM , Krishnaswamy S , Xu A . Serum retinol-binding protein 4 as a marker for cardiovascular disease in women. PLoS One . 2012;7:e48612. doi:10.1371/journal.pone.0048612 23119072
   PubMed Web of Science ®Google Scholar
• Zatterale F , Longo M , Naderi J , et al. Chronic adipose tissue inflammation linking obesity to insulin resistance and type 2 diabetes. Front Physiol . 2020;10:Article No. 1607. doi:10.3389/fphys.2019.01607
   PubMed Web of Science ®Google Scholar
• Jin D , Guo H , Bu SY , et al. Lipocalin-2 is a selective modulator of peroxisome proliferator-activated receptor-γ activation and function in lipid homeostasis and energy expenditure. FASEB J . 2011;25(2):754–764. doi:10.1096/fj.10-165175 20974668
   PubMed Web of Science ®Google Scholar
• Zhang J , Wu Y , Zhang Y , LeRoith D , Bernlohr DA , Chen X . The role of lipocalin-2 in the regulation of inflammation in adipocytes and macrophages. Mol Endocrinol . 2008;22(6):1416–1426. doi:10.1210/me.2007-0420 18292240
   PubMedGoogle Scholar
• Guo H , Jin D , Zhang Y , et al. Lipocalin-2 deficiency impairs thermogenesis and potentiates diet-induced insulin resistance in mice. Diabetes . 2010;59(6):1376–1385. doi:10.2337/db09-1735 20332347
   PubMed Web of Science ®Google Scholar
• Paton CM , Rogowski MP , Kozimor AL , Stevenson JL , Chang H , Cooper JA . Lipocalin-2 increases fat oxidation in vitro and is correlated with energy expenditure in normal weight but not obese women. Obesity . 2013;21:E640–648. doi:10.1002/oby.20507 23640923
   PubMed Web of Science ®Google Scholar
• Xu Y , Ma X , Pan X , He X , Xiao Y , Bao Y . Correlations between serum concentration of three bone-derived factors and obesity and visceral fat accumulation in a cohort of middle aged men and women. Cardiovasc Diabetol . 2018;17:143. doi:10.1186/s12933-018-0786-9 30424752
   PubMed Web of Science ®Google Scholar
• Donath MY , Storling J , Berchtold LA , Billestrup N , Mandrup-Poulsen T . Cytokines and beta-cell biology: from concept to clinical translation. Endocrine Rev . 2008;29(3):334–350. doi:10.1210/er.2007-0033 18048762
   PubMed Web of Science ®Google Scholar
• Li D , Yan Sun W , Fu B , Xu A , Wang Y . Lipocalin‐2: the myth of its expression and function. Basic Clin Pharmacol Toxicol . 2020;127:142–151. doi:10.1111/bcpt.13332 31597008
   PubMed Web of Science ®Google Scholar
• Hu Y , Xue J , Yang Y , et al. Lipocalin-2 upregulation protects hepatocytes from IL1-β-induced stress. Cell Physiol Biochem . 2015;36(2):753–762. doi:10.1159/000430135 26021263
   PubMedGoogle Scholar
• Hansen D , Dendale P , Beelen M , et al. Plasma adipokine and inflammatory marker concentrations are altered in obese, as opposed to non-obese, type 2 diabetes patients. Eur J Appl Physiol . 2010;109:397–404. doi:10.1007/s00421-010-1362-5 20131064
   PubMed Web of Science ®Google Scholar
• Neuparth MJ , Proença JB , Santos-Silva A , Coimbra S . Adipokines, oxidized low-density lipoprotein, and C-reactive protein levels in lean, overweight, and obese Portuguese patients with type 2 diabetes. Obesity . 2013;2013:Article ID 142097.
   Google Scholar
• Raghushaker CR , Shashank T , Manista A . Evaluation of serum biomarkers [Leptin, Adiponectin, CRP, Oxidised-LDL] and lipid parameter in obese with type-2 diabetes mellitus: risk to CVD. J Adv Res Biol Sci . 2013;5(3):250–253.
   Google Scholar
• Liu W , Zhou X , Li Y , et al. Serum leptin, resistin, and adiponectin levels in obese and non-obese patients with newly diagnosed type 2 diabetes mellitus: a population based study. Medicine . 2020;99(6):e19052. doi:10.1097/MD.0000000000019052 32028423
   PubMed Web of Science ®Google Scholar
• Coimbra S , Brandão Proença J , Santos-Silva A , Neuparth MJ . Adiponectin, leptin, and chemerin in elderly patients with type 2 diabetes mellitus: a close linkage with obesity and length of the disease. Biomed Res Int . 2014;2014:Article no, 701915. doi:10.1155/2014/701915
   Web of Science ®Google Scholar
• Rajković N , Zamaklar M , Lalic K , et al. Relationship between obesity, adipocytokines and inflammatory markers in type 2 diabetes: relevance for cardiovascular risk prevention. Int J Environ Res Public Health . 2014;11(4):4049–4065. doi:10.3390/ijerph110404049 24736687
   PubMed Web of Science ®Google Scholar
• Jung C-H , Kim B-Y , Mok J-O , Kang S-K , Kim C-H . Association between serum adipocytokine levels and microangiopathies in patients with type 2 diabetes mellitus. J Diabetes Investig . 2014;5:333–339. doi:10.1111/jdi.12144
   PubMed Web of Science ®Google Scholar
• Li X , Zhao Y , Jin Y , et al. Associations between serum adipocytokines and glycemic tolerance biomarkers in a rural Chinese population. PLoS One . 2017;12(8):e0182273. doi:10.1371/journal.pone.0182273 28786989
   PubMed Web of Science ®Google Scholar
• Tong HV , Luu NK , Son HA , et al. Adiponectin and pro-inflammatory cytokines are modulated in Vietnamese patients with type 2 diabetes mellitus. J Diabetes Invest . 2017;8:295–305. doi:10.1111/jdi.12579
   PubMed Web of Science ®Google Scholar
• Liu C , Feng X , Li Q , Wang Y , Li Q , Hua M . Adiponectin, TNF-α and inflammatory cytokines and risk of type 2 diabetes: a systematic review and meta-analysis. Cytokine . 2016;86:100–109. doi:10.1016/j.cyto.2016.06.028 27498215
   PubMed Web of Science ®Google Scholar
• Lee JM , Kim SR , Yoo SJ , Hong OK , Son HS , Chang SA . The relationship between adipokines, metabolic parameters and insulin resistance in patients with metabolic syndrome and type 2 diabetes. J Int Med Res . 2009;37:1803–1812. doi:10.1177/147323000903700616 20146878
   PubMed Web of Science ®Google Scholar
• Han SJ , Boyko EJ , Fujimoto WY , Kahn SE , Leonetti DL . Low plasma adiponectin concentrations predict increases in visceral adiposity and insulin resistance. J Clin Endocrinol Metab . 2017;102:4626–4633. doi:10.1210/jc.2017-01703 29029184
   PubMed Web of Science ®Google Scholar
• Gariballa S , Alkaabi J , Yasin J , Al Essa A . Total adiponectin in overweight and obese subjects and its response to visceral fat loss. BMC Endocr Disord . 2019;19:55. doi:10.1186/s12902-019-0386-z 31159801
   PubMed Web of Science ®Google Scholar
• Kadowaki T , Yamauchi T , Kubota N , Hara K , Ueki K , Tobe K . Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest . 2006;116:1784–1792. doi:10.1172/JCI29126 16823476
   PubMed Web of Science ®Google Scholar
• Ferris WF , Naran NH , Crowther NJ , Rheeder P , van der Merwe L , Chetty N . The relationship between insulin sensitivity and serum adiponectin levels in three population groups. Horm Metab Res . 2005;37(11):695–701. doi:10.1055/s-2005-870580 16308839
   PubMed Web of Science ®Google Scholar
• Lopez-Jaramillo P . The role of adiponectin in cardiometabolic diseases: effects of nutritional interventions. J Nutr . 2016;146(2):422S–426S. doi:10.3945/jn.114.202432 26764331
   PubMed Web of Science ®Google Scholar
• Petrone A , Zavarella S , Caiazzo A , et al. The promoter region of the adiponectin gene is a determinant in modulating insulin sensitivity in childhood obesity. Obesity . 2006;14(9):1498–1504. doi:10.1038/oby.2006.172 17030959
   PubMed Web of Science ®Google Scholar
• Mohlig M , Wegewitz U , Osterhoff M , et al. Insulin decreases human adiponectin plasma levels. Horm Metab Res . 2002;34:655–658. doi:10.1055/s-2002-38248 12660877
   PubMed Web of Science ®Google Scholar
• Lihn IS , Pedersen SB , Richelsen B . Adiponectin: action, regulation and association to insulin sensitivity. Obesity Rev . 2005;6(1):13–21. doi:10.1111/j.1467-789X.2005.00159.x
   PubMed Web of Science ®Google Scholar
• Mirea AM , Tack CJ , Chavakis T , Joosten LAB , Toonen EJM . IL-1 Family cytokine pathways underlying NAFLD: towards new treatment strategies. Trends Mol Med . 2018;24:458–471. doi:10.1016/j.molmed.2018.03.005 29665983
   PubMed Web of Science ®Google Scholar
• Zhao G , Dharmadhikari G , Maedler K , Meyer-Hermann M . Possible role of interleukin-1β in type 2 diabetes onset and implications for anti-inflammatory therapy strategies. PLoS Comput Biol . 2014;10(8):e1003798. doi:10.1371/journal.pcbi.1003798 25167060
   PubMed Web of Science ®Google Scholar
• Ma L , Su H , Wang Y , et al. Interleukin-1β (IL-1β) C-511T polymorphism is associated with susceptibility to coronary artery disease in type 2 diabetic patients. Eur J Inflamm . 2020;18:1–12. doi:10.1177/2058739220918047
   Web of Science ®Google Scholar
• Juge-Aubry CE , Somm E , Chicheportiche R , et al. Regulatory effects of interleukin (IL)-1, interferon-β, and IL-4 on the production of IL-1 receptor antagonist by human adipose tissue. J Clin Endocrinol Metab . 2004;89:2652–2658. doi:10.1210/jc.2003-031219 15181037
   PubMed Web of Science ®Google Scholar
• Tack CJ , Stienstra R , Joosten LA , Netea MG . Inflammation links excess fat to insulin resistance: the role of the interleukin-1 family. Immunol Rev . 2012;249(1):239–252. doi:10.1111/j.1600-065X.2012.01145.x 22889226
   PubMed Web of Science ®Google Scholar
• Bing C . Is interleukin-1β a culprit in macrophage-adipocyte crosstalk in obesity? Adipocyte . 2015;4(2):149–152. doi:10.4161/21623945.2014.979661 26167419
   PubMed Web of Science ®Google Scholar
• Boni-Schnetzler M , Thorne J , Parnaud G , et al. Increased interleukin (IL)-1beta messenger ribonucleic acid expression in beta-cells of individuals with type 2 diabetes and regulation of IL-1beta in human islets by glucose and auto-stimulation. J Clin Endocrinol Metab . 2008;93(10):4065–4074. doi:10.1210/jc.2008-0396 18664535
   PubMed Web of Science ®Google Scholar
• Morteza A , Nakhjavani M , Ghadiri-Anari A , Esteghamati A , Khalilzadeh O . Serum interleukin-1 and interleukin-6 are correlated neither with oxidized low density lipoprotein, nor with low-grade inflammation in patients with type 2 diabetes. Eur Cytokine Netw . 2011;22:107–112. doi:10.1684/ecn.2011.0282 21636350
   PubMed Web of Science ®Google Scholar
• Joung KH , Kim JM , Choung S , Lee JH , Kim HJ , Ku BJ . Association between IL-1beta and cardiovascular disease risk in patients with newly diagnosed, drug-naïve type 2 diabetes mellitus: a cross-sectional study. Ann Transl Med . 2020;8(5):225. doi:10.21037/atm.2020.01.17 32309372
   PubMed Web of Science ®Google Scholar
• Lee H-M , Kim -J-J , Kim H-J , Shong M , Ku BJ , Jo E-K . Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes. Diabetes . 2013;62:194–204. doi:10.2337/db12-0420 23086037
   PubMed Web of Science ®Google Scholar
• Bastard JP , Maachi M , Lagathu C , et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw . 2006;17:4–12.16613757
   PubMed Web of Science ®Google Scholar